IL17A and chronic obstructive pulmonary disease: It has been suggested that lung inflammation in COPD might be influenced by levels of IL17, which directly increased actin levels associated with the nuclear factor-kappa B (NF-кB) signaling pathway in airways and alveolar walls (Dos Santos et al., 2018).